<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02234206</url>
  </required_header>
  <id_info>
    <org_study_id>Ref.No. ExII(1)/29096/2011</org_study_id>
    <secondary_id>CTRI/2014/01/004281</secondary_id>
    <nct_id>NCT02234206</nct_id>
  </id_info>
  <brief_title>A Clinical Trial to Study the Safety and Efficacy of Chandrakanthi Choornam in Patients With Low Sperm Count</brief_title>
  <official_title>Safety and Efficacy of Chandrakanthi Choornam in Oligospermia - A Preclinical and Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tamil Nadu Dr.M.G.R.Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tamil Nadu Dr.M.G.R.Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an Open clinical trial to study the safety and efficacy of Chandrakanthi Choornam in&#xD;
      40 patients with Oligospermia. Chandrakanthi choornam is a formulation consisting of 25&#xD;
      ingredients. They are Curculigo orchioides -rhizome, Madhuca longifolia - flower, Cinnamomum&#xD;
      verum -bark,Cinnamomum tamala-Leaf, Syzygium aromaticum - flower bud,Coscinium&#xD;
      fenestratum-stem bark,Mesua ferrea-flower, Maerua arenaria-tuber, Adhatoda vasica- seed,&#xD;
      Moringa oleifera-seed, Lawsonia inermis-seed, Vitis vinifera- fruit, Bombax ceiba- gum,&#xD;
      Bambusa aurundinaceae-salt,Phoenix dactilifera- fruit,Ilicium verum- flower, Mucuna&#xD;
      prurita-seed, Cyperus rotundus- rhizome, Glycyrrhiza glabra-root, Tribulus terrestris-fruit,&#xD;
      Cuminum cyminum-seed,Costus speciosus-root,Myrsitica fragrans-seed, Alternanthera&#xD;
      sessilis-seed and asphaltum-mineral. Treatment duration is three months.Study is conducted in&#xD;
      India (Chennai). Primary outcome measure is to see the changes in sperm count, motility and&#xD;
      morphology. Secondary Outcome measure is to see the impact on the harmone level.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      METHODOLOGY OF PROPOSED RESEARCH:&#xD;
&#xD;
      I. Preclinical study II. Clinical study&#xD;
&#xD;
      I. PRECLINICAL STUDY:&#xD;
&#xD;
      Standardization Of The Study Drug&#xD;
&#xD;
        1. Botanical Identification&#xD;
&#xD;
        2. Chemical Identification&#xD;
&#xD;
        3. Preparation of the study drugs:&#xD;
&#xD;
           Formulation: Chandrakanthi choornam Source : Chikicharathna deepam Part II. Pg-168&#xD;
           (Approved sastric book as per drugs &amp; cosmetic act 1940.&#xD;
&#xD;
        4. Chemical methods of testing&#xD;
&#xD;
        5. Pharmacological study : A. Spermotogenic Activity&#xD;
&#xD;
        6. Toxicological study : A. Acute Toxicity B. Long term Toxicity&#xD;
&#xD;
      II. CLINICAL STUDY&#xD;
&#xD;
      Conducted as per the guidelines of GCP accepted by Ayush adapted from the ICH.&#xD;
&#xD;
      A. Pilot study B. Main study&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sperm concentration per milliliter of seminal fluid</measure>
    <time_frame>90 days</time_frame>
    <description>Changes in the total number of sperm cells per milliliter of seminal fluid were evaluated from baseline to three months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of Sperm motility</measure>
    <time_frame>90 days</time_frame>
    <description>Changes in the percentage of total and progressive motility of sperm were evaluated from baseline to three months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of Sperm morphology</measure>
    <time_frame>90 days</time_frame>
    <description>Changes in the percentage of sperm cells with normal forms were evaluated from baseline to three months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact on the hormonal level due to the clinical trial</measure>
    <time_frame>90 days</time_frame>
    <description>Changes in serum Testosterone, LH and FSH were estimated from baseline to three months</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assessment on Safety parameters</measure>
    <time_frame>90 days</time_frame>
    <description>Safety parameters: Liver function test ,Renal function test , Lipid profile, Haematological profile , Blood Glucose, Urinary parameters were assessed from baseline to three months</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Oligospermia</condition>
  <arm_group>
    <arm_group_label>Chandrakanthi choornam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Chandrakanthi Choornam (CKC) - 12gm in milk&#xD;
OD dose; Oral route&#xD;
3 Months - duration&#xD;
Intervention Drug: Chandrakanthi Choornam (CKC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chandrakanthi Choornam (CKC)</intervention_name>
    <description>12gm in milk - OD dose; Oral route; 3 Months ( 90days) - duration&#xD;
Preparation from approved sastric book as per drugs &amp; cosmetic act 1940</description>
    <arm_group_label>Chandrakanthi choornam</arm_group_label>
    <other_name>Nerunjil choornam</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Male infertile Patients with age between 21-45 yrs&#xD;
&#xD;
          -  Marriage history for &gt;1 year&#xD;
&#xD;
          -  Abnormal Sperm count 1-15 million/ml&#xD;
&#xD;
          -  Patients with normal Liver &amp; Renal function test&#xD;
&#xD;
          -  Willing to give specimen of semen before &amp; at the end of the clinical trial&#xD;
&#xD;
          -  Informed patients giving written consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Azoospermia - complete absence of sperm cells in the ejaculate&#xD;
&#xD;
          -  Aspermia - complete lack of semen&#xD;
&#xD;
          -  Necrospermia- Spermatozoa in semen are either immobile or dead.&#xD;
&#xD;
          -  Clinical diagnosis of Varicocele &amp; Hydrocele&#xD;
&#xD;
          -  History of Undescended testis&#xD;
&#xD;
          -  Inguinal hernia on physical examination&#xD;
&#xD;
          -  Male accessory gland infection&#xD;
&#xD;
          -  History of DM, Hypertension and Cardiac disease&#xD;
&#xD;
          -  Any recent medical or surgical illness&#xD;
&#xD;
          -  Underwent treatment for promoting Spermatogenic fertility in last 3 months&#xD;
&#xD;
          -  Other Systemic disease requiring specific therapies&#xD;
&#xD;
          -  Known Thyroid disease&#xD;
&#xD;
          -  Past history of Renal, Hepatic or any other chronic illness in the Patient&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr.B. Akila., M.D (s)</last_name>
    <role>Principal Investigator</role>
    <affiliation>National institute of Siddha</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National institute of siddha</name>
      <address>
        <city>Chennai</city>
        <state>Tamilnadu</state>
        <zip>600047</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <study_first_submitted>August 27, 2014</study_first_submitted>
  <study_first_submitted_qc>September 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2014</study_first_posted>
  <last_update_submitted>September 4, 2014</last_update_submitted>
  <last_update_submitted_qc>September 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tamil Nadu Dr.M.G.R.Medical University</investigator_affiliation>
    <investigator_full_name>Dr.B.Akila., M.D (s)</investigator_full_name>
    <investigator_title>Safety and Efficacy of Chandrakanthi Choornam in Oligospermia - A Preclinical and Clinical Study</investigator_title>
  </responsible_party>
  <keyword>Hypospermatogenesis, Low Sperm Count, Oligozoospermia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oligospermia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

